System and Method for Determining a Hemodynamic Instability Risk Score for Pediatric Subjects
Philips is developing a system configured to determine a hemodynamic instability risk score for a pediatric subject. The system considers the subject’s age and his or her physiological characteristics.
Philips Chief Executive Officer Frans van Houten shrugged off an economic slowdown in China, raising the dividend and starting a new share buyback program as orders for the company’s medical equipment surged.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…